Risk factors for fungemia in children infected with human immunodeficiency virus: A case-control study

Clinical Infectious Diseases

Volumn 23, Issue 3, 1996, Pages 515-521

  Gonzalez, Corina E ^b   Venzon, David ^b   Lee, Sondra ^b   Mueller, Brigitta U ^b   Pizzo, Phillip A ^b   Walsh, Thomas J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; CENTRAL VENOUS CATHETER; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FUNGEMIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOALBUMINEMIA; IMMUNE RESPONSE; INFANT; LYMPHOCYTE COUNT; MALE; MALNUTRITION; PRIORITY JOURNAL; RISK FACTOR;

EID: 0029829110     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinids/23.3.515     Document Type: Article

References (20)

1. Beck-Sagué CM, Jarvis WR, the National Nosocomial Infections Surveillance System. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. J Infect Dis 1993; 167: 1247-51.
2. Stamos JK, Rowley AH. Candidemia in a pediatric population. Clin Infect Dis 1995; 20:571-5.
3. Meunier F, Aoun M, Bitar N. Candidemia in immunocompromised patients. Clin Infect Dis 1992; 14(suppl 1):S120-5.
4. Hibberd PL, Rubin RH. Clinical aspects of fungal infection in organ transplant recipients. Clin Infect Dis 1994; 19(suppl 1):S33-40.
5. Butler KM, Baker CJ. Candida: an increasingly important pathogen in the nursery. Pediatr Clin North Am 1988; 35:543-63.
6. Baley JE, Kliegman RM, Fanaroff AA. Disseminated fungal infections in very low-birth-weight infants: clinical manifestations and epidemiology. Pediatrics 1984; 73:144-52.
7. Bodey GP. Candidiasis in cancer patients. Am J Med 1984; 77(suppl 4D): 13-9.
8. Turner RB, Donowitz LG, Hendley JO. Consequences of candidemia for pediatric patients. Am J Dis Child 1985; 139:178-80.
9. Johnson PR, Decker MD, Edwards KM, Schaffner W, Wright PF. Frequency of Broviac catheter infections in pediatric oncology patients. J Infect Dis 1986; 154:570-8.
10. Lecciones JA, Lee JW, Navarro EE, et al. Vascular catheter-associated fungemia in patients with cancer: analysis of 155 episodes. Clin Infect Dis 1992; 14:875-83.
11. Karabinis A, Hill C, Leclercq B, Tancrède C, Baume D, Andremont A. Risk factors for candidemia in cancer patients: a case-control study. J Clin Microbiol 1988; 26:429-32.
12. Weese-Mayer DE, Fondriest DW, Brouillette RT, Shulman ST. Risk factors associated with candidemia in the neonatal intensive care unit: a case-control study. Pediatr Infect Dis J 1987; 6:190-6.
13. Wey SB, Mon M, Pfaller MA, Woolson RF, Wenzel RP. Risk factors for hospital-acquired candidemia: a matched case-control study. Arch Intern Med 1989; 149:2349-53.
14. Goodrich JM, Reed EC, Mon M, et al. Clinical features and analysis of risk factors for invasive Candida! infection after marrow transplantation. J Infect Dis 1991; 164:731-40.
15. Macdonald L, Baker C, Nadjarian, Chenoweth C. Risk factors for nosocomial candidemia in a pediatric hospital [abstract no J108]. In: Program and abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy (Orlando). Washington, DC: American Society for Microbiology, 1994:106.
16. Marina NM, Flynn PM, Rivera GK, Hughes WT. Candida tropicalis and Candida albicans fungemia in children with leukemia. Cancer 1991; 68:594-9.
17. Walsh TJ, Gonzalez C, Roilides E, et al. Fungemia in children infected with the human immunodeficiency virus: new epidemiologic patterns, emerging pathogens, and improved outcome with antifungal therapy. Clin Infect Dis 1995; 20:900-6.
18. Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep 1992; 41(suppl RR-17):l-19.
19. Centers for Disease Control and Prevention. 1994 revised classification system for human immunodeficiency virus infection in children less than 13 years of age. MMWR Morb Mortal Wkly Rep 1994; 43(suppl RR-12):1-10.
20. Wade N. Immunologic considerations in pediatric HIV infection. J Pediatr 1991; 119(1 Pt 2)(suppl):S5-7.